Farms.com Home   News

Study Models Future Effects of Climate Change on US Corn and Soybean Yields, Production, and Exports

A recent study conducted by the U.S. Department of Agriculture (USDA) Economic Research Service (ERS) modeled how climate-linked changes in temperatures and precipitation might affect future U.S. corn and soybean yields and what that would mean for markets and trade through the middle of the next decade.

The study used 2016 as a base year, and the model estimated an increase in U.S. corn yields but a decrease in soybean yields by the year 2036. These changes would affect U.S. corn and soybean exports. In the model, corn exports are projected to increase 0.36% by 2036, compared with 2016, while soybean exports drop 1.17% for a total decrease for the two crops of as much as US$256 million by 2036.

The U.S. corn yields were estimated to increase 3.1% by 2036, representing historically slow yield growth compared with previous decades. In contrast, soybean yields were projected to decrease by 3%. With these yield changes, the use of land in corn and soybean production also was expected to shift. U.S. corn producers are expected to plant fewer acres of corn because of increased yields while soybean producers are projected to increase acreage to offset the impact of the expected yield decrease.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.